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ABPM – ambulatory blood pressure monitoring 
ADMA – asymmetric dimethylarginine 
ARV – average real variability 
BP – blood pressure 
BRS – baroreceptor reflex sensitivity  
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HF – high frequency 
HR – heart rate 
HRV – heart rate variability 
hs-CRP – high sensitivity C reactive protein 
HTN - hypertension 
ICAM-1 – intercellular adhesion molecule 
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IL-10 – interleukin 10 
IL-6 – interleukin 6 
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ln – log transformed 
mBP – mean blood pressure 
NO – nitric oxide 
nu – normalised units 
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Q̇ - cardiac output 
RPP – rate pressure product 
sBP – systolic blood pressure 
SV – stroke volume 
TFM – Task Force® Monitor 
TNF- - tumor necrosis factor alpha 
TPR – total peripheral resistance 
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Abstract 
 
Objective: Hypertension remains the leading modifiable risk factor for cardiovascular 
disease (CVD). Isometric exercise training (IET) has been shown to be a useful non-
pharmacological intervention for reducing resting blood pressure (BP). This study aimed to 
measure alterations in office BP, ambulatory BP, cardiac autonomic modulation and 
inflammatory and vascular biomarkers following a programme of IET in unmedicated 
hypertensive patients.  
 
Methods: Twenty-four unmedicated stage 1 hypertensive patients (age 43.8±7.3 years; 
height, 178.1±7 cm; weight 89.7±12.8 kg) were randomly assigned in a cross-over study 
design, to 4-weeks of home based IET and control period, separated by a 3-week washout 
period. Office and Ambulatory BP, cardiac autonomic modulation, and inflammatory and 
vascular biomarkers were recorded pre and post IET and control periods.  
 
Results: Clinic and 24-hour ambulatory BP significantly reduced following IET by 12.4/6.2 
mmHg and 11.8/5.6 mmHg in systolic/diastolic BP, respectively (p<0.001 for both), 
compared to the control. The BP adaptations were associated with a significant (p=0.018) 
reduction in the average real variability of 24-hour ambulatory BP following IET, compared 
to control. Cardiac autonomic modulation improved by 11% (p<0.001), baroreceptor reflex 
sensitivity improved by 47% (p<0.001), and interleukin-6 and asymmetric dimethylarginine 
reduced by 10% (p=0.022) and 19% (p=0.023), respectively, which differed significantly to 
the control period.  
 
Conclusion: This is the first evidence of durable BP reduction and wider CVD risk benefits 
of IET in a relevant patient population. Our findings support the role of IET as a safe and 
viable therapeutic and preventative intervention in the treatment of HTN.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Introduction 
 
Systemic hypertension (HTN) remains the leading attributable risk factor for cardiovascular 
disease and all-cause mortality globally [1]. Recent evidence suggests that the prevalence of 
HTN is increasing [2], which places a substantial economic burden on public health services. 
A recent clinical trial reported lower rates of fatal and nonfatal major cardiovascular events 
and all-cause mortality when blood pressure (BP) is treated to within the normal range [3]. 
However, rates of diagnosis remain relatively low and treatment for HTN is frequently 
suboptimal [4], especially in younger adults [5].  
 
Traditional aerobic exercise training is a current guideline lifestyle recommendation for the 
non-pharmacological treatment of HTN [6]. However, a recent meta-analysis demonstrated 
that current exercise guidance provided to reduce BP is unlikely to benefit long-term 
cardiovascular risk [7]. Thus, novel therapeutic exercise training interventions may be of 
particular importance.  
 
Isometric exercise training (IET) has been shown to produce clinically significant reductions 
in resting BP in pre-hypertensive and hypertensive populations [8-10]. In addition, meta-
analytical studies report greater reductions in resting BP following IET, compared to 
traditional aerobic exercise [11]. Mechanisms for the reduction in resting BP include 
modifications in central and peripheral cardiovascular control [8,10,12-15]. However, few 
studies have investigated the wider cardiovascular benefits of IET. Therefore, the aims of this 
study were to investigate changes in office BP, ambulatory BP, cardiac autonomic 
modulation and inflammatory and vascular biomarkers following a 4-week home-based IET 
intervention in a group of unmedicated hypertensive patients. We hypothesize that IET will 
reduce ambulatory BP and inflammatory and vascular biomarkers and improve cardiac 
autonomic modulation.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Method 
 
Study Design 
 
This study was a prospective single centre, randomised cross-over controlled trial. Eligible 
patients recruited were those that satisfied the inclusion and exclusion criteria, which 
included; unmedicated stage 1 hypertension, defined as a blood pressure of 130-139 systolic 
and/or 80-89 diastolic [6], aged between 30 and 65 years old, no history of cardiac or 
metabolic disease, non-smokers and presenting with a normal clinical cardiovascular 
examination and 12-lead electrocardiogram. All participants were physically inactive (self-
reported and defined as not meeting current recommendations) [16] and were not taking any 
acute (<3 months) or chronic medications, including antibiotics.  
 
All procedures for this investigation conformed to the Declaration of Helsinki principles and 
the local ethics committee approved the study (Ref: 12/SAS/122). All participants provided 
signed, written informed consent.   
 
Study Procedures 
 
All tests were performed at Canterbury Christ Church University. Twenty-four (43.8±7.3  
years) unmedicated stage 1 hypertensive participants were randomised in a cross-over design 
to a 4-week programme of IET or 4-week control period (Figure 1), which was separated by a 
3-week washout period. Each participant was required to visit the laboratory on 5-sperate 
occasions. The first visit comprised a continuous incremental isometric exercise test, as 
previously described [14,15], which was used to determine each participants’ IET knee joint 
angle (see online-only Data Supplement). The four remaining laboratory visits comprised the 
recording of physiological data as described below. All participants were required to maintain 
their normal circadian and dietary patterns, fast for 8-hours and abstain from caffeine and 
alcohol for 24-hours before testing, as well as attend the laboratory at the same time of day.  
 
Blood Pressure Measurements 
 
Brachial artery office BP was measured in a temperature controlled room pre and post the 
IET intervention and control period using a validated automated device (Dinamap Pro 200 
Critikon, GE Medical Systems, Freiburg, Germany) and according to current guidelines [6]. 
Ambulatory 24-hour BP monitoring (ABPM) was measured pre and post the IET intervention 
and control period using a commercially available and validated oscillometric brachial cuff 
sphygmomanometer (Welch Allyn 6100 ambulatory BP monitor, Welch Allyn Inc. 
Skaneateles Falls, NY, USA). The participants were asked to perform their usual daily 
activities but were not allowed to exercise during the 24-hour recording period. Systolic BP 
(sBP), mean BP (mBP), diastolic BP (dBP) and heart rate (HR) were measured every 20-
minutes between 6.00am and 10:00pm and every 30-minutes in the remaining time period. 
All BP readings were stored on the device and uploaded to a computer (Welch Allyn 
CardioPerfect Workstation software for Windows, Welch Allyn Inc. Skaneateles Falls, 
NY, USA) for evaluation. The data were analysed for the whole 24-hour period, as well as 
separately for the day time (9.00am to 9:00pm) and the night time (1:00am to 6:00am) period 
[17]. All participants confirmed that they slept during the specified night time hours. The 
average real variability (ARV) of ambulatory sBP, mBP and dBP were calculated as a 
measure of BP variability as previously described [18]. 
     
Cardiac Autonomic Assessment 
 
Cardiac autonomic modulation was assessed using a validated non-invasive and continuous 
beat-to-beat monitoring system (Task Force® Monitor; TFM) [19]. Heart rate variability 
(HRV) as an index of cardiac autonomic function was determined from the oscillating 
fluctuations in the frequency and amplitude of each R-R interval using power spectral 
analysis and applying an autoregressive model. Electrocardiogram (ECG) traces were also 
manually screened to confirm traces were clear of any erroneous data. High (predominantly 
parasympathetic outflow) and low (predominantly sympathetic outflow) [20] frequency 
parameters of HRV were automatically calculated by the TFM and expressed in absolute 
(ms2) and normalised units (nu). Normalisation of the frequency components of HRV has 
proven crucial to the interpretation of these data [21]. The ratio of LF-to-HF (LF:HF ratio) is 
an accepted measure of cardiac sympathovagal balance [22]. Spontaneous baroreceptor 
sensitivity (BRS) was automatically evaluated via the sequence method, based on computer 
identification of a series of successive increases or decreases in sBP and lengthening or 
shortening of the R-R interval [23]. Linear regression of increments or decrements in sBP and 
R-R interval were computed, with only episodes with correlation coeffiencts of r>0.95 
selected. From all regressions, a mean slope of BRS is calculated for each period. All 
parameters were indexed to body surface area.   
 
HR was recorded through a 6-channel ECG and beat-to-beat stroke volume (SV) was 
measured with impedance cardiography via one electrode band applied to the nape of the 
neck and two placed either side of the thorax in line with the xiphoid process. Cardiac output 
(Q̇) was calculated as the product of HR and SV, rate pressure product (RPP) as the product 
of HR and sBP, pulse pressure (PP) as the difference between sBP and dBP, and total 
peripheral resistance (TPR) was calculated according to Ohm’s law. Following 15 minutes of 
supine rest, baseline autonomic and haemodynamic function were recorded continuously for 
5 minutes. All biological signals were recorded with a sample frequency of 1000Hz and 16- 
bit resolution. 
 
Inflammatory Biomarkers  
 
Serum high sensitivity C-reactive protein (hs-CRP) was determined by enzyme-linked 
immunosorbent assay (ELISA; Siemens ADVIA Systems, New York, USA), and serum 
interleukin 6 (IL-6), IL-10 and tumour necrosis factor alpha (TNF-) were also measured by 
ELISA (R&D Systems, Inc. Minneapolis, USA) using standard techniques.  
 
Vascular Biomarkers  
 
Serum asymmetric dimethylarginine (ADMA), vascular cell adhesion molecule 1 (VCAM-1) 
and intercellular adhesion molecule 1 (ICAM-1) were measured by ELISA (R&D Systems, 
Inc. Minneapolis, USA), using standard techniques.   
 
Isometric Exercise Training Intervention     
 
During the IET intervention period, all participants completed a 4-week unsupervised home-
based isometric wall squat training programme. Training was completed 3-days per week for 
4 successive weeks (12 sessions in total) with 48-hours between training sessions. Each 
training session was composed of 4 x 2 minute bouts of isometric wall squat exercise 
interspersed with 2-minutes of seated rest between bouts. All training sessions were 
completed at a participant specific knee joint angle (see online-only Data Supplement) as 
previously described [15,24] and the mean knee joint training angle was 11419. In order to 
monitor training intensity and confirm that the prescribed training angle elicited the required 
HR response, each participant recorded their HR at the end of each stage (Polar RS400 
Computer and a Polar WearLink V2 transmitter, Polar Electro Oy, Kempele, Finland) and 
uploaded their data to a personal online database, which was monitored by the experimenter. 
During the control period, participants were required to maintain their normal daily routine 
for a 4-week period and abstain from any form of exercise they did not habitually perform.  
 
Sample Size Estimation 
 
Based on previous studies utilising home-based isometric exercise training for BP reduction, 
we expected the IET intervention to result in a decrease in resting systolic BP of ≥5 mmHg in 
the training group with no statistically significant change in the control group [25]. This 
difference was considered to be clinically relevant. Using the likely changes (~4.3%) and the 
coefficient of variation of systolic BP (4.6%) from Wiles et al., [25] we estimated a sample 
size of 18 participants, with 80% power, and p<0.05. We estimated the dropout rate to be 20-
30%, leading to an overall sample size of 24 participants.  
 
Statistical Analysis 
 
Continuous variables are expressed as mean ± standard deviation. Analysis of Covariance 
was performed on change scores (post-pre) for the two conditions, with order of the 
intervention included as a covariate in the analysis. Where outcome measures were positively 
skewed these were log transformed (ln) prior to analysis. All data were analysed using the 
statistical package for social sciences (SPSS 22 release version for Windows; SPSS Inc., 
Chicago IL, USA). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Results 
 
All 24 participants completed the IET intervention and control period. Resting office blood 
pressure, daytime ABPM, cardiac autonomic function and haemodynamics were successfully 
acquired on all participants. However, 1-participant refused to wear the ABPM during the 
night, therefore night time BP results are reported from 23 participants. In addition, 
inflammatory and vascular biomarker analysis was performed on 21 participants. 
Importantly, there were no significant differences between measurements at time points 1 and 
3 between or within groups, which confirms that the 3-week washout period was long enough 
for those participants who initially performed IET to return to baseline.  
 
Resting Blood Pressure, Haemodynamics and Cardiac Autonomic Function  
 
As shown in Table 1, resting office sBP, mBP and dBP significantly decreased post IET 
compared to control (-12.4±3.9 mmHg, -8±4.3 mmHg and -6.2±3.8 mmHg respectively, all 
p<0.001). Following IET, there was a significant increase in SV (p<0.001), Q̇ (p=0.003), and 
significant reduction in TPR (p<0.001) compared with the control condition. These results 
were similar when indexed to body surface area. However, there was no significant 
difference (p=0.571) in HR between IET and control conditions (Table 1).  
 
There was an increase in HRV expressed as R-R PSD (ms2) (1031±975), which was 
significantly different to the control period (p<0.001). There was also a significant increase in 
HF (nu) (11.9±17.5%; p=0.017) accompanied by a reciprocal decrease in LF (nu) (-
11.9±17.5%; p=0.017) following IET. 
 
There was no significant difference in LF (ms2) between IET and control conditions (p=0.2). 
However, following IET, an increase in HF (ms2) (540±357; p<0.001) was evident, which 
was significantly different to the control condition (p<0.001). These cardiac autonomic 
responses resulted in a significant decrease in the LF/HF ratio between the IET and control 
conditions (1.86±2.85; p=0.029). In addition, change in BRS was significantly greater 
following IET than control (8.2±5.2 vs 0.03±1.8; p<0.001) (Table 1). 
 
Ambulatory Blood Pressure 
 
As shown in Table 2, 24-hour ambulatory sBP, mBP and dBP decreased post IET (-11.8±3.5 
mmHg, -5.7±4.38 mmHg and -5.6±3.3 mmHg respectively, all of which were significantly 
different to the control period; p<0.001). There were also significant reductions compared to 
the control condition for daytime ambulatory sBP, mBP and dBP (-13.9±4.1 mmHg, -7.4±5 
mmHg and -5.6±4.1 mmHg respectively, all p<0.001) and night time ambulatory sBP, mBP 
and dBP (-9.4±8.5 mmHg, p<0.001; -3.9±2.2 mmHg, p=0.013; -4.9±4.7 mmHg, p=0.002 
respectively). Figure 2 demonstrates the density distribution, mean and individual changes in 
ambulatory sBP, mBP and dBP following IET and control conditions. In addition, Figure 3 
demonstrates the difference in mean hour-by-hour ambulatory BP, pre and post IET for sBP, 
mBP and dBP.     
 
There was no significant differences in 24-hour (p=0.691), daytime (p=0.911) or night time 
(p=0.073) ambulatory HR between IET or control conditions (Table 2). As a result of the BP 
changes following IET, 24-hour ambulatory, day time and night time pulse pressure (-
5.8±7.08 mmHg; p<0.001; -7.39±10 mmHg; p<0.001, and -4.25±6.22 mmHg; p=0.003, 
respectively) and RPP (-1118±706; p<0.001; -1254±767; p<0.001, and -1073±1041; 
p<0.001, respectively) significantly reduced compared to the control condition.  
 
As shown in table 2, 24-hour ambulatory ARV for sBP significantly decreased post IET 
compared to control (-2.33±1.4 mmHg; p=0.018); however, there was no significant change 
in ARV for mBP or dBP (1.7±2.8 mmHg, p=0.076; -1.42±1.2 mmHg; p=0.1, respectively). 
There was a significant reduction in daytime systolic ARV (-2.45±1.5 mmHg; p=0.022). In 
addition, there were significant reductions in night time ARV for mBP and dBP post IET (-
3.1±1.9 mmHg; p=0.001, and -2.21±1.8 mmHg; p=0.008, respectively) with no significant 
change in night time ARV for sBP (-2.62±1.6 mmHg; p=0.127).  
 
Biochemical Variables 
 
Following IET, IL-6 (ln) and ADMA (ln) significantly decreased (-0.04±0.07, p=0.022 and -
0.05±0.11, p=0.023, respectively) compared with the control period. There was no significant 
change in hs-CRP, TNF-, VCAM-1 or ICAM-1 following IET or control condition.  
 
There was no significant change in IL-10 (ln) following IET (1.24±0.2 to 1.25±0.2, p=0.19). 
However, there was a significant reduction in the IL-6/IL-10 ratio (0.91±0.26 to 0.86±0.24, 
p=0.02) following IET. 
 
 
 
 
 
Discussion 
 
To the best of our knowledge, the present study is the first to prospectively investigate the 
wider cardiovascular benefits of IET, including ABPM, cardiac autonomic modulation, 
central haemodynamics and inflammatory and vascular biomarkers in a randomised cross 
over controlled study design. Importantly, this is the first study that investigated a non-
medicated hypertensive population utilising home based wall squat isometric exercise. 
Confirming our initial hypothesis, IET reduced office BP, ambulatory BP, IL-6, ADMA, and 
improved cardiac autonomic modulation.  
 
Blood Pressure 
 
In the general population, ABPM is more predictive of mortality compared to office BP [26] 
and is recognised to be more predictive of target organ damage [27], which supports its use 
within the current study. However, the magnitude of BP reduction following IET was similar 
between office BP (12.4 mmHg sBP and 6.2 mmHg dBP) and ambulatory BP (11.8 mmHg 
sBP and 6 mmHg dBP) in our study. Nonetheless, the magnitude of BP reduction following 
IET in our population is of clinical significance, since it is greater than the average BP 
reduction (9.1 mmHg sBP and 5.5 mmHg dBP) achieved with a single, standard dose anti-
hypertensive drug [28] and is associated with reduced cardiovascular mortality [29]. Similar 
to most pharmacological treatments for BP [28], greater reductions in BP have been shown in 
groups with higher baseline BP values following exercise training [11]. The magnitude in BP 
reduction reported in our study is greater than traditional exercise training in normotensive 
and hypertensive individuals [11], as well as following a recent home-based wall squat IET 
intervention in participants with BP in the normal range [15]. As such, it may be postulated 
that wall squat IET may exert a greater anti-hypertensive effect in patients with more severe 
hypertension and/or act as an adjunctive therapy in those with multiple anti-hypertensive 
agents or resistance hypertension. However, this has not been tested in our study and requires 
further research. Our results also show a significant reduction in day time and night time BP, 
as well as PP and RPP. These parameters are associated with reduced mortality and 
myocardial work. Importantly, in our study, 2-particpants were initially classified as non-
dippers (4% nocturnal BP drop), which may be an important indicator of advanced vascular 
disease [30]. However, following IET these participants had a mean nocturnal BP dip of 
16%. As such, IET may be an important non-pharmacological intervention in non-dippers.    
 
Research has demonstrated that a greater tendency for BP to vary within a 24-hour period, 
favours the development of cardiac [31] and vascular damage [32], as well as cardiovascular 
mortality [33]. IET significantly reduced 24-hour ambulatory and night time systolic, mean 
and diastolic ARV as well as day time systolic ARV, which may have prognostic 
significance. Increased sympathetic activity, altered baroreceptor reflex sensitivity and 
vascular dysfunction are factors known to increase BP variability and cardiovascular events, 
which are hallmarks of HTN [34]. In addition, the increased BP variability may induce direct 
endothelial damage and alter autoregulation capacities of target organs, which may be 
directly responsible for cardiovascular events [34].  
 
Cardiac Autonomic Modulation 
 
Evidence suggests that autonomic dysfunction, which is characterised by greater sympathetic 
drive, may have a causative or co-causative role in the aetiology and progression of human 
HTN [35,36]. The beneficial effect of exercise training on cardiac autonomic modulation, 
with a tonic decrease in sympathetic activity and augmented vagal modulation, has been well 
documented in clinical and experimental studies. Our study demonstrated a significant 
increase in the total power spectrum of HRV and HF component, with no significant change 
in the LF component, which resulted in a significant reduction in the LF/HF ratio following 
IET. This finding suggests an increase in cardiac vagal control following IET. Previous work 
from our laboratory demonstrated similar acute responses following a single isometric 
exercise session [14] and a potential mechanism for the improved cardiac autonomic 
modulation was improved BRS, which is under the control of central command. Indeed, BRS 
significantly increased following IET, which supports this mechanistic pathway. The arterial 
baroreflex is an important short and long-term regulator of arterial BP and research has 
demonstrated that BRS is inversely related to mBP and positivity correlated with HRV [37].  
Our findings are consistent with this response and suggest that a more sensitive baroreflex 
may function to reduce BP throughout 24-hours, which is supported by our ambulatory BP 
results. It may be postulated that IET promotes alterations in cardiovascular control sites, via 
neural remodelling or endogenous factors, such as the nitric oxide pathway, which would 
facilitate vagal cholinergic activity, improved baroreflex response and heightened antagonism 
of cardiac sympathetic activity [38], all of which act to reduce arterial BP.   
 
Inflammatory and Vascular Biomarkers 
 
The cascade from the development of HTN to adverse cardiovascular events remains unclear. 
However, altered vascular function and early structural remodelling are considered markers 
of subclinical organ damage in HTN and are independent predictors of CVD [39]. The 
endothelium plays a vital role in maintaining vascular homeostasis, and vascular endothelial 
dysfunction is characterised by a pro-inflammatory, pro-thrombotic and pro-constrictive 
phenotype [40]. Endothelium derived nitric oxide (NO) plays a major role in flow mediated 
vasodilatation. In addition, NO inhibits platelet aggregation, adhesion of monocytes and 
leukocytes to the endothelium and inhibits vascular inflammation, which renders NO a 
significant anti-atherosclerotic molecule [41]. Systemic low-grade inflammation leads to 
increased ADMA, that may induce endothelial dysfunction and accelerate atherosclerosis. 
Indeed, previous research in healthy humans demonstrated that IL-6 is associated with 
increased ADMA levels and endothelial dysfunction [42]. Our results have demonstrated that 
IET significantly reduces IL-6 and ADMA. Although implied, an increase in NO bio-
availability and associated vasodilatory capacitance, through a reduction in endogenous 
inhibitors of NO synthases may be an important mechanistic pathway for the BP reductions 
observed in hypertensive participants following IET. The significant reduction in TPR in our 
study and prior IET and aerobic exercise training studies [43,44] support this concept. Larger 
prospective IET interventions are required to explore inflammatory and vascular biomarker 
responses further, since CRP, TNF , VCAM-1 and ICAM-1 did not significantly change 
following training.  
 
Our study has several limitations. First, despite being a home-based (self-directed) exercise 
intervention, participants were in regular contact with the experimenter, which is likely an 
important stimulus for sustained behaviour. Research has demonstrated that as contact is 
withdrawn, intervention effect declines [7]. As such, the effects of contact withdrawal on 
outcome measures is unknown. Second, the IET intervention is short (4-weeks) and further 
research is required to ascertain the long-term benefits. Third, our study only included male 
Caucasian individuals and the relative transference to female and different ethnic 
populations, which are known to be at greater risk of HTN is unknown. Finally, the authors 
also acknowledge the inherent limitations of a cross over design due to the potential carry 
over effect and bias. However, a 3-week washout period was selected to ensure adequate time 
for participants to return to baseline. Importantly, no significant difference within and 
between groups were seen between visit 1 and 3 of the study, indicating sufficient washout. 
In addition, each participant verbally confirmed that they maintained their usual habits during 
the study, with the exception of IET.  
 
Perspectives 
 
We have demonstrated that unsupervised home-based wall squat IET performed at a 
relatively high intensity is well tolerated, safe and is associated with clinically significant 
reductions in BP as well as other important markers of cardiovascular risk. The potential 
importance of our findings is substantial, considering a 10 mmHg lower usual sBP and 5 
mmHg lower usual dBP is associated with a 40% lower risk of stroke and 30% lower risk of 
mortality from ischemic heart disease and other vascular causes throughout middle age [29]. 
Although the 4-week training intervention maybe of inadequate duration to support any 
claims for the long-term benefits of IET and/or ascertain changes in target organ damage and 
mortality benefit, our data is the first to demonstrate sustained BP lowering, improved cardiac 
autonomic modulation, in particular BRS, and reductions in IL-6 and ADMA, all of which 
are associated with improved cardiovascular health. Moreover, IET may provide a viable, 
cost effective and favourable alternative to traditional non-pharmacological interventions for 
the management of HTN, due to a lower exercise time commitment and home-based model. 
Although longer-term studies are required, our findings support the role of IET as a 
therapeutic and preventative intervention in the treatment of HTN.  
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Figure Legend 
 
Figure 1: Study flow diagram illustrating the randomised cross over design and time points of 
physiological measures acquired. Note: * = indicates the measurement time point for 
acquiring resting and ambulatory blood pressure, cardiac autonomic modulation, 
hemodynamics and blood sampling.  
 
Figure 2: Illustrates the density distribution, average and individual delta change in; A, 
Ambulatory sBP; B, Ambulatory mBP; C, Ambulatory dBP following IET and control 
conditions.  
 
Figure 3: Illustrates the difference in mean hour-by-hour ambulatory BP, pre and post IET 
for; A, Ambulatory sBP; B, Ambulatory mBP; C, Ambulatory dBP.     
 
 
